Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
J Infect
; 83(2): 237-279, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1225296
ABSTRACT
The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
Topics:
Vaccines
Limits:
Aged
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
J Infect
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS